Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

$4.40 0.06 (1.38%)

High $4.46	Low $4.23	Trades 1,020	Turnover $2,463,536	Volume 565,229
30 June 2023 at 4:10pm

Market Cap (21-Aug) $272,173,504 (439th)	Close (30-Jun) $4.40 0 (0%)	Volume (30-Jun) 565,229	Shortsold (17-Aug) 1,854,888 (2.28%) (139th)
52w High $6.50	52w Low $2.04	P/E 263.16	EPS -1.04

Short Interest

ASIC data, 17 Aug 2026

% Shorted

2.28%

vs 2.28% prior report

Most Shorted Rank

139th

of 697 shorted ASX stocks

Peak Short

13.53%

May 2017

Days to Cover

6.7

at 50d avg vol

View full short position history →

	Subject
	MYX MYX Ann: Mayne Pharma adds generic ABSORICA to US portfolio
	1 (current) 2 3
	MYX MYX Ann: Notification regarding unquoted securities - MYX
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: 2021 Full Year Investor Presentation
	MYX MYX Ann: 2021 Full Year Media Release
	MYX MYX Ann: Appendix 4E and Statutory Accounts
	MYX MYX Ann: Mayne Pharma board renewal and new Chairman
	MYX MYX Ann: Class action proceeding
	MYX MYX Ann: Notification of cessation of securities - MYX
	MYX MYX Ann: Lapse of performance rights
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Mayne Pharma expands Australian dermatology portfolio
	MYX MYX Ann: NEXTSTELLIS oral contraceptive now available in the US
	MYX MYX Ann: NEXTSTELLIS FDA exclusivity & phase III data published
	MYX MYX Ann: Becoming a substantial holder
	MYX MYX Ann: Appendix 2A and Notice under ASX Listing Rule 3.10A
	MYX MYX Ann: Change in substantial holding
	MYX MYX Ann: FDA approval of novel oral contraceptive NEXTSTELLIS
	MYX MYX Ann: Appendix 3G
	MYX MYX Ann: New data on NEXTSTELLIS presented at ISSWSH conference
	MYX MYX Ann: Change in substantial holding
	MYX MYX Ann: 2021 Half Year Investor Presentation
	MYX MYX Ann: 2021 Half Year Media Release
	MYX MYX Ann: Half Yearly Report and Accounts
	MYX MYX Ann: Mayne Pharma launches Microgestin 24 FE tablets in the US
	MYX MYX Ann: Mayne Pharma successfully extends debt facility
	MYX MYX Ann: Change of Director's Interest Notice
	MYX MYX Ann: Appendix 3G
	MYX MYX Ann: 2020 AGM Results
	MYX MYX Ann: Chairman and CEO's Addresses to Shareholders
	MYX MYX Ann: Mayne Pharma Board Renewal
	MYX MYX Ann: New data on Mayne Pharma's TOLSURA presented at IDWeek 2020
	MYX MYX Ann: Lapse of rights and AGM Notice of Meeting clarification

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
21-Aug	$3.26	224,973	-0.09 (2.69%)
20-Aug	$3.35	231,117	+0.12 (3.72%)
19-Aug	$3.23	151,791	0.00 (0.00%)
18-Aug	$3.23	198,564	-0.07 (2.12%)
17-Aug	$3.30	232,715	+0.10 (3.12%)
14-Aug	$3.20	254,141	-0.04 (1.23%)
13-Aug	$3.24	122,798	-0.03 (0.92%)
12-Aug	$3.27	80,488	+0.01 (0.31%)
11-Aug	$3.26	335,975	+0.01 (0.31%)
10-Aug	$3.25	240,461	+0.10 (3.17%)
07-Aug	$3.15	374,427	+0.05 (1.61%)
06-Aug	$3.10	339,370	-0.03 (0.96%)
05-Aug	$3.13	393,692	+0.08 (2.62%)
04-Aug	$3.05	703,095	+0.12 (4.10%)
03-Aug	$2.93	1,533,634	+0.27 (10.15%)
9 up, 5 down, and 1 flat days

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care Biotech Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mayne Pharma Group Health Care
Biotech Healthcare Pharmaceuticals